Placental site trophoblastic tumor with an ovarian metastasis

Placental site trophoblastic tumors (PSTT) are the rarest form of gestational trophoblastic disease (GTD). The clinical management of PSTT differs from the other forms of GTD as surgery plays a more important role. The most common metastatic sites are the lung, liver, and vagina while spread to the adnexa is relatively unusual. We describe a case of a 35-year-old woman presenting with PSTT and ovarian metastasis who was successfully treated with radical hysterectomy, bilateral oophorectomy, pelvic lymph node dissection, and postoperative chemotherapy. The case highlights the possibility of ovarian metastases despite normal preoperative imaging and confirms the value of multidisciplinary management of this rare illness

[1]  R. Scully,et al.  Placental site trophoblastic tumor: A study of 55 cases and review of the literature emphasizing factors of prognostic significance. , 2006, Gynecologic oncology.

[2]  M. Wells,et al.  Placental site trophoblastic tumour: clinical features and management. , 2005, Gynecologic oncology.

[3]  T. Yahata,et al.  Placental site trophoblastic tumor presenting as subaponeurotic metastasis. , 2005, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[4]  W. Gotlieb,et al.  Placental site trophoblastic tumor: outcome of five cases including fertility preserving management. , 2005, Gynecologic oncology.

[5]  A. Buda,et al.  Placental site trophoblastic tumor: an overview. , 2004, The Journal of reproductive medicine.

[6]  D. Mutch,et al.  Diagnosis and treatment of gestational trophoblastic disease: ACOG Practice Bulletin No. 53. , 2004, Gynecologic oncology.

[7]  I. McNeish,et al.  Twenty-five years' clinical experience with placental site trophoblastic tumors. , 2002, The Journal of reproductive medicine.

[8]  M. Seckl,et al.  Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  R. Fisher,et al.  Management of placental site trophoblastic tumors. , 1998, The Journal of reproductive medicine.

[10]  R. Fisher,et al.  Placental site trophoblastic tumor: molecular analysis and clinical experience. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.